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Particle rigidity is tuned by varying the amounts of interfacial water between the PLGA core and lipid shell of the hybrid NPs; this is achieved by altering the injection order of the PLGA and lipid-poly(ethylene glycol) (PEG) organic solutions in the microfl uidic chip. The microfl uidic device shown in Scheme 1 consists of two stages: 1) The fi rst stage comprises three inlets and a straight synthesis microchannel; 2) The second stage is composed of one centered inlet and a spiral mixing channel (see Supporting Information (SI), Figure S1 for more details). We synthesized particles of varying water content and rigidity using the same chip but different order of the introducing reagents. In mode 1, the fi rst stage is used for generating PLGA NPs through interfacial precipitation, while the second stage forms lipid-coated NPs as a result of hydrophobic attraction between the lipid tail and PLGA (P-L NPs; Scheme 1 A, Figure S2 (SI)). In mode 2, we change the injection order by introducing the lipid solution at the fi rst stage and the PLGA solution at the second stage. In this way, lipids form into a liposome in aqueous solution at the fi rst stage, followed by re-assembly onto the surface of PLGA NPs at the second stage through effective mixing (P-W-L NPs; Scheme 1 B, Figure S2 (SI)). The throughput of NPs by a single chip is 41 mL h −1 (≈8 mg h −1 for P-W-L NPs, and ≈6.5 mg h −1 for P-L NPs). For both mode 1 and mode 2, transmission electron microscopy (TEM) images ( Figure 1 A; Figure S2 , SI) show complete lipid coverage on the surface of PLGA NPs. The different injection order of the solutions may result in the presence of interfacial water between the PLGA core and lipid shell of the P-W-L NPs (mode 2) but not in P-L NPs (mode 1), which is confi rmed by cryogenic TEM (cryo-TEM Figure 1 B; see also SI). For the P-L NPs, the lipid shell is tightly attached to the PLGA core, while for the P-W-L Even though much research has shown that nanoparticles (NPs) can enter the cell differently depending on their particular size, shape, or mechanical properties, little is known on how the rigidity of NPs affects their entrance into the cell. [1] [2] [3] By adopting a microfl uidic platform, we synthesized NPs of varying water content and rigidity but with the same chemical composition, size, and surface properties, to show the rigidityregulated cellular uptake of core-shell NPs with a lipid shell rigid or "hard" NPs (less interfacial water between the polymeric core and lipid shell) enter cells more easily than fl exible ("soft") ones. Simulations reveal that the "soft" NPs are deformed and thus energetically unfavorable for cellular uptake. Our data therefore pave the way for the design of mechanically favorable NPs for controlled interactions between nanomaterials and cells and better NP-based medical applications.
Lipid-covered polymeric NPs serve well both as a delivery system for drugs-because of their high effi ciency and low risk for side effects-and as model systems for understanding the mechanisms of the biological effects of nanomaterials. [4] [5] [6] [7] [8] [9] So far, in addition to the chemical composition, size, biocompatibility, and surface properties of the lipid shell of the NPs having infl uence on the cellular uptake and anticancer effi cacy, it has been recognized that different lipid-polymer structures may result in variations in the particle rigidity (the resistance of the particle to deform), thus affecting the cellular uptake of NPs and the effi cacy of treatment. [10] [11] [12] The link between the rigidity of NPs, and their cellular uptake effi ciency, however, is still missing, which is crucial for the design of NPs for drugdelivery. One major challenge of bulk synthesis lies in the
COMMUNICATION
NPs, there is a thin water layer between the lipid shell and PLGA core. To estimate the amount of water inside the P-W-L NPs, we measured the radius of the different components of the NPs. The radius of the inner PLGA core is about 27.6 nm, and that of the outer lipid shell is about 31.1 nm. The lipid layer of the P-W-L NP is about 4 nm. Given the radii of the inner and outer spheres, we can calculate the volume of interfacial water to be 3.8 × 10 4 nm 3 , accounting for almost 30% of the total volume of P-W-L NP. The resolution of the cryo-TEM images obtained with a Tecnai 12 electron microscope appears to be low in comparison to some of the high-resolution protein images, and we may explore it further in future work.
To further characterize the presence of water inside the hybrid NPs generated by two modes of the microfl uidic chip, we used Rhodamine B (RhB) to label the water encapsulated by the NPs during fabrication by applying a 200-µ M RhB solution (in water) as the water sheath in both mode 1 and 2. After synthesis, NPs were separated from free RhB in solution as well as the RhB attached to the surface of the NPs by a Sephadex G50 size-exclusion column (Pharmacia Biotech, NJ, USA), and we concentrated the NPs by evaporating the solution down to 1 mL with a fl ow of nitrogen. The fl uorescence emission spectrum of the separated NPs was measured at the excitation wavelength of 510 nm by an LS55 fl uorospectrophotometer (Perkin Elmer, MA, USA). The fl uorescence intensity of the P-W-L NPs is approximately 50% higher than that of the P-L NPs (Figure 1 C) . RhB is a water-soluble dye, and thus most of the RhB encapsulated in the NPs should be in the water layer. There may be a small amount of RhB in the lipid shell and polymer matrix, but this amount should be equal inside the P-L NPs and P-W-L NPs. As a result, the higher fl uorescence of P-W-L NPs can only be from the RhB that is encapsulated inside the interfacial water layer.
The existence of more interfacial water inside P-W-L NPs than P-L NPs is associated with the manufacturing mechanisms of the two-stage microfl uidic device, and we used molecular dynamics (MD) simulations to reproduce the process of formation of hybrid NPs (more details in the SI). In mode 1, when lipids are injected at the second stage, they quickly assemble onto the PLGA NPs before forming liposomes due to the strong hydrophobic interaction between the lipid tail and PLGA ( Figure 2 A, where lipids are red and blue while PLGA is green). The formation of P-L NPs is indicated by the full coverage of the lipid layer (Figure 2 B) . In mode 2, since the lipids have already formed liposomes at the fi rst stage, the PLGA solution injected at the second stage and the resultant PLGA NPs cannot enter the liposome unless they are assisted by the vortex in the spiral mixing channel. in the PLGA NP. In this case, water molecules fi ll between the lipid shell and PLGA to form the core-water-shell structure of the P-W-L NPs (Figure 2 D) . We emphasize that this P-W-L NP structure only forms if we have the spiral structures at the second stage. It fails to form in straight channels of the same cross-section and while using the same fl ow rates. We only observe PLGA NPs and liposomes rather than the core-shell PLGA-lipid NPs in the latter, probably due to ineffi cient mixing inside the straight channel at the second stage ( Figure S3, SI) . The different order of injection and the possible subsequent generation of the interfacial water layer in P-W-L NPs and water-free P-L NPs would give rise to a distinct rigidity for each of the particle types. To validate, we measured the rigidity of P-L and P-W-L NPs usng atomic force microscopy (AFM) with a Multimode 8 Atomic Force Microscope (Bruker) and Nanoscope analysis software (Bruker). For P-L and P-W-L NPs with a size of 40 nm, the Young's modulus of the P-L NPs is 1.20 ± 0.11 GPa, which is higher than that of the P-W-L NPs (0.76 ± 0.07 GPa) (Figure 2 E-G, Table 1 ). The Young's modulus of the P-L NPs is close to that of pure PLGA NPs, which is approximately 1 GPa, [ 22 ] and three orders of magnitude higher than that of liposomes. [ 23 ] We further note that both the P-L NPs and P-W-L NPs exhibit much better long-term stability than the hydrophobic PLGA NPs (without shell) and hollow liposomes (without core) ( Figure S4, SI) .
Since lipid-covered NPs with distinct rigidity are available, we tested their cellular uptake by incubating the lipid-covered NPs and liposomes with HeLa cells (a type of cancer cell) stained with Hoechst 33342 (blue). We show in Figure 3 A-C the results of the cellular uptake of "hard" P-L NPs and "soft" P-W-L NPs. For better visualization, we used DiD (red) and TopFluor-PE (green) to label the PLGA core and lipid shell, respectively. After a 5-h incubation, HeLa cells incubated with P-L NPs display higher green (lipid shell) and red (PLGA core) CME: Clathrin-mediated endocytosis.
fl uorescence intensities than those incubated with P-W-L NPs (both on the cell membrane and in the cytoplasm), suggesting a signifi cantly higher cellular uptake of the more rigid NPs (P-L NPs) compared with the less rigid ones (P-W-L NPs; Figure 3 A, B) . HeLa cells incubated with liposomes of similar size have less green fl uorescence in the cytoplasm than lipid-covered NPs do (Figure 3 C) . This rigidity-regulated cellular uptake of NPs was also observed by co-incubation of human umbilical vein endothelial cells (HUVECs) with P-L and P-W-L NPs; HUVECs prefer to take up the more rigid P-L NPs as well ( Figure S5 , SI). To distinguish the means via which cells internalize these NPs, three endocytosis inhibitors (CPZ for the inhibition of clathrin-mediated endocytosis, EIPA for the inhibition of macropinocytosis, and Genistein for the inhibition of caveolae-mediated endocytosis) and hypothermia treatment (4 °C, inhibition of endocytosis) were applied to HeLa cells before co-incubation with hybrid NPs. [ 24 ] HeLa cells treated with CPZ and hypothermia show reduced uptake of P-L and P-W-L NPs, indicating that both NP types are internalized through clathrin-mediated endocytosis (Figure 3 D) .
To test the ability of these NPs with varying water content and rigidity in cancer treatment, we manufactured hybrid dual-drug-loaded (doxorubicin, DOX, and combretastatin A4, CA4) P-L and P-W-L NPs by adding CA4 into the lipid solution, and DOX into the PLGA solution before microfl uidic synthesis. The entrapment effi ciency (EE) of DOX and CA4 are 98.0% and 90.8%, respectively, in P-L NPs, and 97.3% and 95.3%, respectively, in P-W-L NPs ( Figure S6, SI) . In-vitro experiments imply that dual-drug-loaded P-L NPs can kill more HeLa cells than both P-W-L NPs encapsulating drugs and free drugs of the same concentrations (DOX: 0.384 ng mL −1 , CA4: 1.536 ng mL −1 ) (Figure 3 E) . Since the mechanism of in-vivo uptake of NPs is complicated, here we mainly investigate the rigidity-regulated uptake of NPs at the cellular level.
Comparing P-L NPs with P-W-L NPs (including liposomes), the NPs have similar shape, size, composition, surface molecules and internalization pathways ( Table 1 ). The major difference is the rigidity of the NPs related to their internal structure. To understand the mechanism of rigidity-regulated cellular uptake of NPs, we conducted MD simulations to reproduce the internalization process of the NPs into the cell ( Figure 4 ; Movie S1, SI). For the rigid P-L NP, it is fully wrapped by the cell membrane and internalized smoothly (Figure 4 A) . For the less rigid P-W-L NP, however, it undergoes signifi cant deformation during the internalization before it is fi nally trapped within the cell membrane (Figure 4 B) . The deformation of the NP impedes its entry into the cell. [ 11 ] The combination of particle rigidity with deformation suggests an energy penalty for NPs getting through the cell membrane. To illustrate this concept, we analyzed the elastic deformation energy of the membrane when a spherical NP is very rigid and does not deform, in contrast to the case when the NP can deform to an ellipsoidal shape while entering the cell. www.advmat.de www.MaterialsViews.com the Canham-Helfrich's framework [ 25 ] and considering a spherical NP with a 20-nm radius and an ellipsoidal NP with the same volume and an aspect ratio of λ = 0.5 (where λ is defi ned as a ratio of the minor and major axes of the ellipsoid), we construct a dimensionless parameter σ = σK . [ 26 ] The elastic deformation energy of the membrane is a combination of the bending ( E bending ) and tension ( E tension ) energies; it is expressed as: [ 25 ] E E E c c dS dS 
where c 1 and c 2 are principal curvatures of the membrane surface, ψ is the angle tangent to the membrane profi le, and dS are the elements of the membrane surface. Through energy minimization of the total energy, we will obtain the elastic deformation energy of the membrane as a function of the wrapping fraction. [ 27 ] The elastic deformation energy as a function of the wrapping fraction for spherical and ellipsoidal NPs reveals that complete wrapping of ellipsoidal NPs requires about 30% more energy than spherical ones ( Figure S7 , SI). This may partly explain why the less rigid and more fl exible NPs are relatively diffi cult for cellular uptake. As shown in our MD simulation, the more fl exible NPs are able to deform themselves into ellipsoidal NPs where more binding energy is required to overcome the bending energy to complete the internalization ( Figure S7, SI) . Recent studies indicate that the Young's modulus and stiffness of the less rigid, "soft" hydrogel particles (i.e., poly(methacrylic acid) (PMA) hydrogel particles) could be tuned over an order of magnitude by controlling the cross-linker concentration. [ 28 ] Despite the low Young's modulus (less than several mega-Pascals) of the less rigid hydrogel particles compared to the lipid-covered PLGA NPs (i.e., P-L NPs; ≈1 GPa), the hydrogel particles with tunable rigidity remain promising for novel therapeutic applications and the construction of biomimetic models such as the blood capillary. [ 29 ] Rigidity is important for biology, [ 30, 31 ] but we may be the fi rst to demonstrate that it is also important in drug delivery. To the best of our knowledge, this is the only report to test the biological effects of the varying rigidity of nanoscale particles of the same composition, surface chemistry, and size. We extended our understanding by exploring the relationships among the polymer-lipid structure, the rigidity of the NPs for drug delivery, and cellular uptake effi ciency. We developed a two-stage microfl uidic chip that can be readily scaled up to produce NPs of the same chemical composition, size, and surface properties, but varying amounts of water and rigidity. It enabled us to explore how the rigidity of NPs regulates the cellular uptake and to elucidate the intrinsic mechanism. Given the only signifi cant difference between the NPs we have presented is the rigidity, our experiments suggest that rigidity can dramatically alter the cellular uptake effi ciency, with more rigid NPs able to move more easily through membranes. The mechanisms revealed here suggest that tuning the rigidity of NPs is an appealing way to improve therapeutic effi ciency. Combined with the experimental approach we have developed, we expect the results presented in this work to pave a new way to design mechanically favorable NPs for better NP-based drug delivery and possibly other medical applications.
Supporting Information
Supporting Information is available from the Wiley Online Library or from the author.
